How Can Ozempic Help You Lose Weight?

Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management that has become widely used for weight loss because it reduces appetite by up to 40% in clinical studies. The medication works by signaling your brain's satiety centers and slowing the rate at which food leaves your stomach, creating lasting fullness between meals. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies to all 50 states, with pricing that remains flat regardless of your dose strength.

The Science Behind Semaglutide for Weight Loss

Semaglutide mimics a natural hormone your body produces after eating, triggering a cascade of signals that tell your brain you're satisfied sooner than you normally would be. This GLP-1 pathway activation reduces hunger-driving hormones like ghrelin while increasing satiety signals, creating a biological shift toward eating smaller portions. Multiple randomized controlled trials demonstrate that people using semaglutide consume 500–700 fewer calories daily without consciously restricting food, which translates to sustainable weight loss over weeks and months.

Beyond appetite suppression, semaglutide slows gastric emptying—the speed at which your stomach pushes food into your small intestine. When food moves more slowly through your digestive system, you feel full longer and experience fewer cravings between meals. This dual mechanism (central appetite reduction plus delayed digestion) makes semaglutide unique among weight loss medications, addressing hunger at both the brain and gut level.

Semaglutide Dosing and Weight Loss Results

Most people begin semaglutide at a low starting dose (0.25 mg weekly) to allow their body to adapt, then gradually increase every four weeks until reaching an effective maintenance dose—typically between 1.0 and 2.4 mg weekly. Your dose may need to go up as your body becomes accustomed to the medication, but your price won't change; PlexusDx charges a flat monthly rate regardless of strength. Clinical trials show average weight loss of 5–15% of body weight over six months at standard doses, with some individuals losing significantly more depending on their starting weight and adherence.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How PlexusDx Makes Semaglutide Accessible and Affordable

PlexusDx partners exclusively with licensed 503A compounding pharmacies that legally prepare semaglutide injections tailored to your prescription, allowing the company to serve all 50 states without requiring insurance or membership fees. Compounded semaglutide is $189 per month month-to-month across three commitment tiers, meaning you lock in the same price regardless of whether your doctor increases your dose to manage your weight more effectively. All PlexusDx medications are HSA and FSA eligible, providing additional tax-advantaged savings for qualified accounts.

The compounding model removes insurance delays and prior authorization hurdles that often prevent people from accessing semaglutide, putting the medication within reach for those without coverage or with high deductibles. PlexusDx also offers oral semaglutide and combination therapies like GLP-Squared (a dual-compound injection of semaglutide and tirzepatide) for patients who don't respond optimally to single-agent therapy or prefer different formulations.

Side Effects and Safety Considerations for Semaglutide

The most common side effects of semaglutide are gastrointestinal: nausea, vomiting, constipation, or diarrhea occur in 20–50% of users, especially during the first two weeks at each dose increase. These effects typically resolve within three to five days as your body adjusts, and taking your injection on a day when you plan lighter meals can minimize discomfort. Serious side effects are rare but include pancreatitis (severe abdominal pain) and gallbladder issues; contact your healthcare provider immediately if you develop these symptoms.

Semaglutide is not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2) due to animal study concerns, though human risk remains unclear. Pregnant or breastfeeding women should not use semaglutide, and those with diabetic retinopathy or severe kidney disease require medical supervision. PlexusDx connects you with licensed healthcare providers who review your complete medical history and contraindications before prescribing.

Genetic Testing to Optimize Your Weight Loss Plan

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predisposition to GLP-1 pathway sensitivity means your healthcare provider can anticipate which side effects you're most likely to experience and can proactively manage them—for example, someone with certain FTO variants may benefit from a slower dose escalation schedule to minimize nausea while still achieving optimal weight loss.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on semaglutide injections?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What clinical evidence supports semaglutide for weight loss?

The STEP clinical trial program demonstrated that semaglutide 2.4 mg weekly produced an average weight loss of 9.6–12.4% of body weight over 68 weeks compared to 2.6% with placebo. Sustained weight loss continued for at least one year when patients remained on the medication, making it one of the most effective pharmacological weight loss options available.

Does PlexusDx require insurance, and can I use HSA or FSA?

PlexusDx requires no insurance or membership fees and serves all 50 states with compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan. Yes, all medications including injections are eligible for HSA and FSA reimbursement, which can significantly reduce your out-of-pocket costs.

Are compounded semaglutide injections as safe as FDA-approved versions?

PlexusDx sources compounded semaglutide exclusively from licensed 503A compounding pharmacies, which must meet strict federal quality, sterility, and potency standards under FDA oversight. While compounded medications are not FDA-approved as branded drugs, 503A compounding is federally legal and pharmacists use FDA-grade ingredients prepared according to established protocols, making safety comparable to branded options for most patients.

Can the Precision Peptide Genetic Test tell me if semaglutide will work for me?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.